1. Home
  2. UP vs VTVT Comparison

UP vs VTVT Comparison

Compare UP & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wheels Up Experience Inc.

UP

Wheels Up Experience Inc.

BUY

Current Price

$3.40

Market Cap

134.2M

ML Signal

BUY

Logo vTv Therapeutics Inc.

VTVT

vTv Therapeutics Inc.

BUY

Current Price

$30.87

Market Cap

129.7M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
UP
VTVT
Founded
2013
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
134.2M
129.7M
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
UP
VTVT
Price
$3.40
$30.87
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $54.71
AVG Volume (30 Days)
★ 109.5K
32.5K
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 14.29
N/A
EPS
N/A
★ N/A
Revenue
★ $736,495,000.00
N/A
Revenue This Year
$193.34
N/A
Revenue Next Year
$12.65
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.36
$19.80
52 Week High
$10.09
$44.00

Technical Indicators

Market Signals
Indicator
UP
VTVT
Relative Strength Index (RSI) 37.13 43.91
Support Level $3.14 $29.48
Resistance Level $4.00 $34.65
Average True Range (ATR) 0.32 1.22
MACD 0.03 0.02
Stochastic Oscillator 33.72 30.51

Price Performance

Historical Comparison
UP
VTVT

About UP Wheels Up Experience Inc.

Wheels Up Experience Inc is a provider of on-demand private aviation. The company offers a private aviation solution with a large and diverse aircraft fleet, delivered through a mix of charter solutions and its membership program that utilizes its controlled aircraft fleet and a network of safety-vetted charter operators. Through its partnership firm, it provides members and customers with an offering across private and premium commercial travel. It generates the majority of its revenue from member and customer flights through its membership program and charter solutions, as well as from membership fees and other activities and services, including group charter flights, cargo flights, and special missions. Geographically, the company generates maximum revenue from the United States.

About VTVT vTv Therapeutics Inc.

vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small-molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin (TTP399), a novel, small-molecule, liver-selective glucokinase activator (GKA) currently being evaluated as a potential oral adjunctive therapy to insulin for the treatment of type 1 diabetes (T1D). In addition, the company is also engaged in the research and development of other candidates in its pipeline through collaborations with academic partners and license agreements, which include TTP273, HPP737, TTP-RA, Mavodelpar (HPP593), HPP971, and HPP3033, being studied and developed to counter various chronic diseases.

Share on Social Networks: